INMInMed Pharmaceuticals Inc.
Health Care
Net Cash Provided by (Used in) Operating Activities revised down 4.3% for FY 2025
This is the 2nd largest revision in INM's history.
Net Cash Provided by (Used in) Operating Activities·FY 2025
Notable restatement-$8.1M▼ 4.3%
was-$7.8M
Revised down in a S-4/A.
Amended filing
As reported · Sep 23, 2025S-4/A · Sep 30, 2026us-gaap:NetCashProvidedByUsedInOperatingActivitiesVerify against SEC filingsShow
As reported-$7.8M
Accepted 2025-09-230001213900-25-090210
Restated-$8.1M
Accepted 2026-09-300001193125-26-407792
OperatingCashFlow · reported 5 times · point-in-time, survivorship-free. Every figure traces to its filing above.
Track this the moment it happens
Get a signal the next time INM — or any company on your watchlist — restates a number. Every signal lands with the diff and its source filing.